Literature DB >> 3527988

Regulation of staphylococcal toxic shock syndrome toxin-1 and total exoprotein production by magnesium ion.

J T Mills, A W Dodel, E H Kass.   

Abstract

The effect of Mg2+ on in vitro production of extracellular proteins and, specifically, of toxic shock syndrome toxin-1 (TSST-1), by Staphylococcus aureus in a chemically defined medium was examined. As previously observed, the organisms did not proliferate in the absence of divalent cations. Low levels of Mg2+ (0.02 to 0.04 mM) permitted submaximal proliferation and elevated production of exoproteins. When the Mg2+ concentration was raised to 0.4 mM, multiplication was optimal and exoprotein levels were depressed. Ca2+ and Mn2+ diminished the effect of limiting Mg2+. The increased levels of exoproteins were not due to cell lysis or leakage since intracellular TSST-1 levels were not high enough to account for the increase in extracellular TSST-1 and since the intracellular enzyme, lactate dehydrogenase, was not found in culture supernatants. Cells cultured in low levels of Mg2+ remained in logarithmic growth longer than did those cultured in high concentrations of Mg2+ and, unlike the latter, produced exoproteins throughout the logarithmic growth phase. Low Mg2+ had no effect on cultures in the stationary phase, and organisms cultured in low Mg2+ recovered fully when transferred to high Mg2+. We conclude that, when cultured in medium deficient in Mg2+, S. aureus responds early in the growth cycle by increasing production of many extracellular proteins, including TSST-1.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3527988      PMCID: PMC260845          DOI: 10.1128/iai.53.3.663-670.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  A model for the regulation of bacterial extracellular enzyme and toxin biosynthesis.

Authors:  G Coleman; S Brown; D A Stormonth
Journal:  J Theor Biol       Date:  1975-07       Impact factor: 2.691

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Production of a cholinesterase-solubilizing factor from a Cytophaga sp. by continuous cultivation.

Authors:  A Bovallius
Journal:  Can J Microbiol       Date:  1969-05       Impact factor: 2.419

4.  Teichoic acids and membrane function in bacteria.

Authors:  S Heptinstall; A R Archibald; J Baddiley
Journal:  Nature       Date:  1970-02-07       Impact factor: 49.962

5.  Control of production of toxic-shock-syndrome toxin-1 (TSST-1) by magnesium ion.

Authors:  J T Mills; J Parsonnet; Y C Tsai; M Kendrick; R K Hickman; E H Kaśs
Journal:  J Infect Dis       Date:  1985-06       Impact factor: 5.226

6.  Growth characteristics of group A streptococci in a new chemically defined medium.

Authors:  I van de Rijn; R E Kessler
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

7.  Effect of magnesium on production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus.

Authors:  P M Schlievert
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

8.  The mechanism of protein secretion across membranes.

Authors:  B D Davis; P C Tai
Journal:  Nature       Date:  1980-01-31       Impact factor: 49.962

9.  Induction of human interleukin-1 by toxic-shock-syndrome toxin-1.

Authors:  J Parsonnet; R K Hickman; D D Eardley; G B Pier
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

10.  Control of teichoic acid and teichuronic acid biosyntheses in chemostat cultures of Bacillus subtilis var. niger.

Authors:  D C Ellwood; D W Tempest
Journal:  Biochem J       Date:  1969-01       Impact factor: 3.857

View more
  7 in total

1.  Production of toxic shock syndrome toxin 1 by Staphylococcus aureus requires both oxygen and carbon dioxide.

Authors:  R A Ross; A B Onderdonk
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Virulence of Staphylococcus aureus mutants altered in type 5 capsule production.

Authors:  A Albus; R D Arbeit; J C Lee
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

3.  Detection and quantitation of toxic shock syndrome toxin 1 in vitro and in vivo by noncompetitive enzyme-linked immunosorbent assay.

Authors:  P M Rosten; K H Bartlett; A W Chow
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

4.  Effects of in vitro and in vivo growth conditions on expression of type 8 capsular polysaccharide by Staphylococcus aureus.

Authors:  J C Lee; S Takeda; P J Livolsi; L C Paoletti
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

5.  Detection of Staphylococcus aureus carrying the gene for toxic shock syndrome toxin 1 by quantum-dot-probe complexes.

Authors:  Dan Wang; Hui Chen; Hua Li; QiZhi He; XingHua Ding; Le Deng
Journal:  J Fluoresc       Date:  2011-01-28       Impact factor: 2.525

6.  Development of a defined medium and two-step culturing method for improved exotoxin A yields from Pseudomonas aeruginosa.

Authors:  I I Blumentals; R M Kelly; M Gorziglia; J B Kaufman; J Shiloach
Journal:  Appl Environ Microbiol       Date:  1987-09       Impact factor: 5.005

7.  Impact of the Regulators SigB, Rot, SarA and sarS on the Toxic Shock Tst Promoter and TSST-1 Expression in Staphylococcus aureus.

Authors:  Diego O Andrey; Ambre Jousselin; Maite Villanueva; Adriana Renzoni; Antoinette Monod; Christine Barras; Natalia Rodriguez; William L Kelley
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.